FDA Drug recall D-0573-2023
DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7
- FDA Drug
- Class I
- ongoing
- Published 2023-05-10
On 2023-05-10 the FDA classified a Class I recall of DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7 by Gadget Island, citing marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatm….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0573-2023 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2023-04-26 |
| Published | 2023-05-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Gadget Island |
| Distribution | US |
Product
DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7.
Reason
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Identifiers
| upc | 675799376027 |
|---|---|
| code_info | Lot/Item#: OMS760-B, Exp: 12/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0573-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.